Warning! GuruFocus detected
1 Medium warning sign
with 6469.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Great Tree Pharmacy Co Ltd
ISIN : TW0006469000
Compare
Compare
Traded in other countries / regions
6469.Taiwan IPO Date
2014-12-29Description
Great Tree Pharmacy Co Ltd is engaged in the management and trade of various drugs, health products, goods for mothers and babies, and cosmetics products. The firm also provides coordinated medicine procurement services to various clinics, outpatient centers, and medical communities. Besides, the company is also an agency for domestic and foreign healthcare products sold in clinics, outpatient centers, and medical communities.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.37 | |||||
Equity-to-Asset | 0.3 | |||||
Debt-to-Equity | 1.67 | |||||
Debt-to-EBITDA | 3.52 | |||||
Interest Coverage | 13.61 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 3.27 | |||||
Beneish M-Score | -2.5 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13.6 | |||||
3-Year EBITDA Growth Rate | 16.1 | |||||
3-Year EPS without NRI Growth Rate | 17.6 | |||||
3-Year FCF Growth Rate | -4.6 | |||||
3-Year Book Growth Rate | 21.3 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 12.16 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 10.85 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 50.34 | |||||
9-Day RSI | 44.72 | |||||
14-Day RSI | 44.53 | |||||
3-1 Month Momentum % | 30.17 | |||||
6-1 Month Momentum % | 2.13 | |||||
12-1 Month Momentum % | -21.19 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.38 | |||||
Quick Ratio | 0.71 | |||||
Cash Ratio | 0.47 | |||||
Days Inventory | 87.78 | |||||
Days Sales Outstanding | 14.94 | |||||
Days Payable | 49.74 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.95 | |||||
Dividend Payout Ratio | 0.61 | |||||
3-Year Dividend Growth Rate | 93.7 | |||||
Forward Dividend Yield % | 1.95 | |||||
5-Year Yield-on-Cost % | 30.83 | |||||
3-Year Average Share Buyback Ratio | -1.4 | |||||
Shareholder Yield % | -0.66 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 28.03 | |||||
Operating Margin % | 4.64 | |||||
Net Margin % | 3.94 | |||||
FCF Margin % | 4.32 | |||||
ROE % | 20.58 | |||||
ROA % | 6.01 | |||||
ROIC % | 9.1 | |||||
3-Year ROIIC % | 8.13 | |||||
ROC (Joel Greenblatt) % | 14.7 | |||||
ROCE % | 11.98 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 31.61 | |||||
Forward PE Ratio | 25.82 | |||||
PE Ratio without NRI | 31.64 | |||||
Shiller PE Ratio | 54.72 | |||||
Price-to-Owner-Earnings | 22.57 | |||||
PEG Ratio | 1.21 | |||||
PS Ratio | 1.25 | |||||
PB Ratio | 5.84 | |||||
Price-to-Tangible-Book | 5.94 | |||||
Price-to-Free-Cash-Flow | 29.04 | |||||
Price-to-Operating-Cash-Flow | 19.03 | |||||
EV-to-EBIT | 27.45 | |||||
EV-to-EBITDA | 14.57 | |||||
EV-to-Revenue | 1.44 | |||||
EV-to-FCF | 30.56 | |||||
Price-to-GF-Value | 0.61 | |||||
Price-to-Projected-FCF | 1.94 | |||||
Price-to-DCF (Earnings Based) | 1.01 | |||||
Price-to-DCF (FCF Based) | 2.52 | |||||
Price-to-Median-PS-Value | 1.47 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.27 | |||||
Price-to-Graham-Number | 2.89 | |||||
Earnings Yield (Greenblatt) % | 3.64 | |||||
FCF Yield % | 3.55 | |||||
Forward Rate of Return (Yacktman) % | 23.36 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Great Tree Pharmacy Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 17,274.254 | ||
EPS (TTM) (NT$) | 5.045 | ||
Beta | -0.58 | ||
3-Year Sharpe Ratio | 0.08 | ||
3-Year Sortino Ratio | 0.12 | ||
Volatility % | 12.05 | ||
14-Day RSI | 44.53 | ||
14-Day ATR (NT$) | 8.419763 | ||
20-Day SMA (NT$) | 169.7 | ||
12-1 Month Momentum % | -21.19 | ||
52-Week Range (NT$) | 137 - 250.028266 | ||
Shares Outstanding (Mil) | 131.89 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Great Tree Pharmacy Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Great Tree Pharmacy Co Ltd Stock Events
Event | Date | Price (NT$) | ||
---|---|---|---|---|
No Event Data |
Great Tree Pharmacy Co Ltd Frequently Asked Questions
What is Great Tree Pharmacy Co Ltd(ROCO:6469)'s stock price today?
The current price of ROCO:6469 is NT$159.50. The 52 week high of ROCO:6469 is NT$250.03 and 52 week low is NT$137.00.
When is next earnings date of Great Tree Pharmacy Co Ltd(ROCO:6469)?
The next earnings date of Great Tree Pharmacy Co Ltd(ROCO:6469) is .
Does Great Tree Pharmacy Co Ltd(ROCO:6469) pay dividends? If so, how much?
The Dividend Yield %  of Great Tree Pharmacy Co Ltd(ROCO:6469) is 1.95% (As of Today), Highest Dividend Payout Ratio of Great Tree Pharmacy Co Ltd(ROCO:6469) was 0.66. The lowest was 0.14. And the median was 0.33. The  Forward Dividend Yield % of Great Tree Pharmacy Co Ltd(ROCO:6469) is 1.95%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |